兄弟科技(002562) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥620,868,894.16, representing a 33.38% increase year-over-year, while the year-to-date revenue was ¥1,905,877,936.97, up 34.15% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2021 was ¥11,433,197.83, a decrease of 62.28% year-over-year, and year-to-date net profit was ¥2,981,052.25, down 97.07% compared to the previous year[2] - The total operating revenue for the third quarter of 2021 was CNY 1,905,877,936.97, an increase of 34% compared to CNY 1,420,731,358.94 in the same period last year[19] - The net profit for the third quarter of 2021 was CNY 2,981,052.25, a significant decrease from CNY 101,879,829.30 in the previous year, indicating a decline of approximately 97%[20] Cash Flow and Liquidity - The company reported a significant decline in cash flow from operating activities, with a net outflow of ¥240,025,756.28, representing a 111.35% decrease year-over-year[7] - The company's cash and cash equivalents decreased from 748,081,305.76 RMB at the end of 2020 to 227,431,333.93 RMB by September 30, 2021, a decline of approximately 69.7%[15] - The cash flow from operating activities for the third quarter was CNY 1,517,878,791.82, compared to CNY 1,281,499,287.86 in the same period last year, showing an increase of 18.5%[23] - The total cash inflow from investment activities was 531,349,293.30 CNY, while cash outflow was 920,818,843.39 CNY, resulting in a net cash flow of -389,469,550.09 CNY[25] - Cash inflow from financing activities amounted to 691,511,666.67 CNY, with cash outflow of 495,828,122.39 CNY, leading to a net cash flow of 195,683,544.28 CNY[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,449,545,785.22, reflecting a 1.70% increase from the end of the previous year[2] - The total liabilities increased to CNY 2,449,843,818.65 from CNY 2,331,756,313.34, marking a rise of approximately 5%[17] - The total current assets as of September 30, 2021, amount to 1,950,511,814.96 RMB, compared to 1,918,397,938.14 RMB at the end of 2020, reflecting a slight increase of about 1.7%[15] - Total liabilities amounted to CNY 2,331,756,313.34, with current liabilities at CNY 1,361,184,437.38 and non-current liabilities at CNY 970,571,875.96[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 48,486[9] - The largest shareholder, Qian Zhida, holds 24.22% of shares, amounting to 257,395,438 shares, with 193,046,578 shares pledged[9] Research and Development - Research and development expenses increased by 42.98% year-over-year, amounting to ¥65,740,258.93, indicating a focus on innovation and new product development[7] - Research and development expenses for the third quarter were CNY 65,740,258.93, up from CNY 45,978,360.50, reflecting a 43% increase year-over-year[20] Investment Activities - Investment income for the period was ¥3,854,016.97, a 112.48% increase compared to the previous year, reflecting higher returns from financial investments[7] - The company plans to invest a total of 2.5 billion RMB in the construction of an international pharmaceutical industry base, with 1.5 billion RMB allocated for fixed assets and 1 billion RMB for R&D and other investments[13] - The company has completed the acquisition of 100% equity in LANXESS CISA PROPRIETARY LIMITED, which is now a wholly-owned subsidiary[11] Employee Compensation - The company paid 225,401,164.47 CNY in employee compensation, an increase from 206,173,163.07 CNY year-over-year[24] - The company has a total of CNY 37,494,544.72 in employee compensation payable, indicating its commitment to employee remuneration[29] Other Financial Metrics - The weighted average return on equity was 1.08%, down 0.35% from the previous year, indicating a decline in profitability[2] - The company reported a basic and diluted earnings per share of CNY 0.003 for the third quarter, down from CNY 0.113 in the previous year[21] - The company experienced a significant decline in other comprehensive income, reporting a tax-adjusted net amount of -CNY 30,108,951.15 compared to -CNY 127,798,212.22 in the previous year[21] - The total comprehensive income includes other comprehensive losses amounting to CNY -59,491,271.85, impacting overall equity[30] Audit and Compliance - The company has not undergone an audit for the third quarter report, which may affect the reliability of the financial data presented[30] - The company adjusted its financial statements in accordance with new leasing standards, impacting the balance sheet[26]